Preterm Delivery Clinical Trial
Official title:
Can Cervical Length Measurement With Embryo Transfer Catheter Predict Preterm Deliveries in ICSI Patients?
The aim of this study is to examine the potential value of cervical length (CL) measurement
with embryo transfer catheter in the prediction of spontaneous preterm deliveries in
intracytoplasmic sperm injection (ICSI) cycles.
Preterm birth is the leading cause of perinatal death and handicap in children. It is clear
that ICSI pregnancies are at high risk groupfor preterm delivery (PTD). In singletons there
is an estimated two-fold increased risk following ICSI.
CL measurement with ultrasound in mid-trimester (22-24 weeks) is the best method for the
prediction of PTD: The shorter the CL, the higher risk of PTD. Recent evidence suggests that
at first trimester (11-13 weeks), the risk for PTD is inversely related to CL. It has been
shown that the measurement of CL on pregnancy is an effective method for identification of
the group at high risk for PTD.
In embryo transfer, catheter is placed the through cervical canal. The method we will use in
this study, CL measurement with transfer catheter, will give more precise results than
measurement with ultrasound.
No study has been performed to evaluate the prediction of PTD by analyzing measurements of
CL, preconceptionally. Our study will be the first in this topic.
There is a certain disadvantage of measuring CL during pregnancy: The effectiveness of
prophylactic administrations (progesterone, cervical cerclage etc.) may be inversely related
to the gestation at which treatment is initiated. If we know the risk of PTD before
gestation, single embryo transfer will be preferred to avoid from multiple pregnancies that
also increase the relative risk of PTD, in ICSI pregnancies.
Cervical length measurement protocol: The physician inserted a sterile Collin vaginal
speculum; the cervix was exposed and gently cleaned with sterile gauze pads. Cervical mucus
was gently removed with a syringe if abundant. A nurse concomitantly performed
transabdominal ultrasound scan. Estimated cervical length is determined before transfer
procedure. The Sure View Wallace Embryo Replacement Catheter (No. CE118; Smith Medical,
Hythe, Kent, UK). There are marked lines on the surface of catheter that show distances to
half centimeters. The catheter has a sliding guide fixed at external cervical os. Correct
position of the catheter is replaced guide on external os, and guide's endpoint is on
internal cervical os. In relation to the internal os was verified on the scan. If required,
re-fixation of sliding guide to external os will also be performed. After loading embryos,
the length between the guide and the end of catheter will be noted.
Data collection protocol: We will obtain data on pregnancy outcome from the hospital
computerized records or the records from family practitioners of the women. We will record
birth weeks as major outcome. The obstetric records of all patients will be examined to
determine whether any exclusion criteria are present.
;
Primary Purpose: Screening
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03304782 -
Fitbit Activity Tracker to Predict Risk of Preterm Birth
|
||
Recruiting |
NCT02420743 -
Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery
|
||
Completed |
NCT01665378 -
Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes
|
N/A | |
Completed |
NCT01119963 -
Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)
|
Phase 2/Phase 3 | |
Completed |
NCT00141908 -
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
|
Phase 2 | |
Recruiting |
NCT05278130 -
Serial Screening and Treatment of Bacterial Vaginosis Trial
|
N/A | |
Terminated |
NCT03596125 -
Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP)
|
Phase 2/Phase 3 | |
Recruiting |
NCT03123926 -
Spontaneous Preterm Birth Marker Test
|
N/A | |
Completed |
NCT00201643 -
A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome
|
Phase 4 | |
Completed |
NCT01353807 -
Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health
|
N/A | |
Terminated |
NCT02545127 -
Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely
|
Phase 2 | |
Completed |
NCT02371356 -
Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal Health
|
||
Active, not recruiting |
NCT01009723 -
Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
|
N/A | |
Completed |
NCT00883324 -
Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum
|
N/A | |
Completed |
NCT00615550 -
PREGNANT Short Cervix Trial
|
Phase 3 | |
Completed |
NCT02694679 -
Randomized Controlled Trial of Social Network Targeting in Honduras
|
N/A | |
Completed |
NCT01031017 -
Prophylactic Administration of Natural Progesterone in the Prevention of Preterm Delivery in Twin Pregnancies
|
Phase 4 | |
Completed |
NCT00329914 -
Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
|
Phase 2 | |
Completed |
NCT00331695 -
Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery
|
Phase 4 | |
Completed |
NCT01818518 -
Neonatal Outcome by Reason for Delivery
|